secwatch.observer — SEC 8-K summary
======================================

Issuer:     Petros Pharmaceuticals, Inc. (PTPI)
CIK:        0001815903
Form:       8-K
Filed at:   2024-03-22T23:59:59+00:00
Accession:  0001104659-24-037906
Event type: other
Sentiment:  neutral
Materiality: 0.35
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Petros enters waiver/amendment with investors covering Dec 2023 equity awards and warrant terms
--------------------------------------------------------------------------------

- Waives breach from Dec 21, 2023 issuance of 348,711 shares/options; deems them Excluded Securities.
- Amends Section 4(c) of Warrants clarifying Black Scholes Value rights in Fundamental Transactions.
- Waiver and Amendment effective as of December 31, 2023, entered March 21, 2024.
- No additional consideration paid to investors; all holders of Preferred Stock and Warrants are party.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815903/000110465924037906/0001104659-24-037906-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815903/000110465924037906/tm249589d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-037906

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer